HL7 - Version 2.8.2


Segment CTI: Clinical Trial Identification (Studienidentifizierung)

Seq Description German Interpretation Length C.LEN Table r/o/c Rep# Item Data Structure Section
1 Sponsor Study ID Studien-ID des Sponsors


R
01011 EI 7.8.4.1
2 Study Phase Identifier ID der Studienphase


C
01022 CWE 7.8.4.2
3 Study Scheduled Time Point Zeitmarke (relativer Zeitpunkt) im Studienprotokoll

9999 O
01055 CWE 7.8.4.3

Used within following Message Structures:

CCI_I22 Collaborative Care Information (11.7.2)
CCI_I22 Collaborative Care Information (11.7.2)
CCM_I21 Collaborative Care Message (11.6.1)
CCM_I21 Collaborative Care Message (11.6.1)
CCR_I16 Collaborative Care Referral (11.6.2)
CCR_I16 Collaborative Care Referral (11.6.2)
CCR_I16 Collaborative Care Referral (11.6.2)
CCU_I20 Collaborative Care Referral (11.6.6)
CCU_I20 Collaborative Care Referral (11.6.6)
CQU_I19 Collaborative Care Referral (11.7.1)
CQU_I19 Collaborative Care Referral (11.7.1)
OMG_O19 General Clinical Order Message (4.4.4)
OML_O21 Laboratory Order Message (4.4.6)
OML_O33 Laboratory Order - Multiple Order Per Specimen Mes (4.4.8)
OML_O35 Laboratory Order - Multiple Order Per Container of (4.4.10)
OML_O39 Specimen Shipment Centric Laboratory Order Message (4.4.12)
OMQ_O57 (4.4.19)
OPL_O37 Population/Location-Based Laboratory Order Message (4.4.16)
ORG_O20 General Clinical Order Acknowledgment Message (4.4.5)
ORU_R01 Observation Message (7.3.1)
ORX_O58 (4.4.20)
OUL_R22 Observation Message (7.3.8)
OUL_R23 Observation Message (7.3.9)
OUL_R24 Observation Message (7.3.10)
RAS_O17 Pharmacy/Treatment Administration (4.A.11)
RDE_O11 Pharmacy/Treatment Refill Authorization Request (4.A.5)